MJH Life Sciences COVID-19 Coalition

MJH Life Sciences COVID-19 Coalition

MJH Life Sciences, health care media company, recently announced that on September 15 they will officially start the MJH Life Sciences COVID-19 Coalition. This project was made with participant of top health care thought leaders across a variety of medical disciplines.

“Springing from MJH’s mission to improve quality of life through healthcare communications, education, and research, the MJH Life Sciences COVID-19 Coalition was formed to help keep healthcare professionals up-to-date and informed on the science and latest learnings on COVID-19,” – authors said.

In the result COVID-19 Coalition should equip providers with the resources they need to enhance patient outcomes as they navigate through the coronavirus pandemic.

People, that into the Coalition, showed themselves as experts who will serve as an advisory panel. The national level experts will spread and generate accurate, up-to-the-minute information on the pandemic’s ever-evolving impact on health care professionals and the patients they treat in the form of live webinars, white papers, infographics, and more.

“There is still much confusion among health care providers as they navigate patient care during the pandemic,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™. “This is why we’ve assembled some of the brightest and most prominent thought leaders in health care to provide the latest and best guidance and direction. The COVID-19 Coalition series builds off MJH’s recent successes with two previous COVID-focused webinars, “COVID-19: A Race for a Vaccine” and “COVID-19: Debating the Road Back to School

The First members Of The MJH Life Sciences COVID-19 Coalition Advisory Panel Become:

  • Margaret Liu, M.D., CEO, PAX Therapeutics; foreign adjunct professor, Karolinska Institutet in Stockholm; adjunct full professor, University of California, San Francisco.
  • Jason M. Pogue, Pharm.D., BCPS, BCIDP, clinical professor, department of clinical pharmacy, University of Michigan College of Pharmacy; infectious diseases clinical pharmacist, Michigan Medicine.
  • Saskia Popescu, Ph.D., MPH, MA, CIC, infectious disease epidemiologist and infection preventionist, adjunct professor, department of epidemiology and biostatistics, Mel & Enid Zuckerman College of Public Health, University of Arizona.
  • Angela Rasmussen, Ph.D., associate research scientist, Center for Infection and Immunity, Columbia University Mailman School of Public Health.
  • Paul E.Sax, M.D., clinical director, division of infectious diseases, Brigham and Women’s Hospital; professor of medicine, Harvard Medical School.
  • Tina Q. Tan, M.D., FAAP, FIDSA, FPIDS, professor of pediatrics, Feinberg School of Medicine, Northwestern University; pediatric infectious diseases attending; medical director, International Patient Services Program; codirector, Pediatric Travel Medicine Clinic; director, International Adoptee Clinic at Ann & Robert H. Lurie Children’s Hospital of Chicago.

The main questions will be:

  • What are the interactions between the seasonal influenza virus and SARS-CoV-2?
  • How do we manage co-infections?
  • How do we prioritize testing and diagnosis?
  • What are some effective strategies for expanding vaccine coverage?
  • What steps can be taken to cut transmission and preserve the capacity and function of health systems?

The first online conference will start at 6PM ET, September, 15. The main topic of webinar was chosen, “Battling Dual Threats: Flu and COVID-19 Converge,” the webinar would least about an hour, and will be free for everyone who wants to join.

Be the first to comment on "MJH Life Sciences COVID-19 Coalition"

Leave a comment

Your email address will not be published.